Freelite® & Hevylite®
Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform
Freelite® & Hevylite®
Binding Site | Freelite Kit Contents
Freelite® & Hevylite®
Untitled
Serum free light chain assays (Freelite®) are recommended by the NCCN Clinical Practice Guidelines in Oncology and the Internat
Freelite® Human Kappa Free kit for use on the SPAPLUS For in vitro diagnostic use Product code: LK016.L.S
PDF) Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Freelite® & Hevylite®
Freelite® & Hevylite®
PDF) Quantitative Serum Free Light Chain Assay - Analytical Issues
Freelite® & Hevylite®
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Together Freelite & Hevylite provide optimal detection of monoclonal gammopathies
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
